相关实验视频

Updated: Jun 30, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

电子血糖管理系统改善了血糖控制,减少了糖尿病患者接受冠状动脉旁路手术的并发症:一项随机对照试验

Alexandre Barbosa Câmara de Souza¹, Marcos Tadashi Kakitani Toyoshima², Priscilla Cukier¹

¹Department of Endocrinology and Metabolism, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Journal of diabetes science and technology

|August 3, 2024

概括

胰岛素APP电子血糖管理系统 (eGMS) 在冠状动脉旁路移植 (CABG) 手术后改善了2型糖尿病 (T2DM) 患者的血糖控制并减少了不良事件,提供了具有成本效益的解决方案.

科学领域:

心脏病学心脏病学
内分泌学在内分泌学.
医疗信息学医疗信息学

背景情况:

住院高血糖会增加糖尿病患者接受冠状动脉旁路移植 (CABG) 手术的风险.
电子血糖管理系统 (eGMS) 显示出改善医院环境中的血糖控制 (GC) 的潜力.
评估了InsulinAPP协议在优化GC和减少CABG后不良结果方面的有效性.

研究的目的:

评估InsulinAPP协议在治疗CABG后2型糖尿病 (T2DM) 患者高血糖症的有效性.
为了比较InsulinAPP协议对T2DM患者在CABG后的传统护理的结果.
确定InsulinAPP协议对不良事件,住院和成本的影响.

主要方法:

一项前性,随机的,开放的标签研究,涉及100名成年T2DM患者在CABG后.
患者被随机分为两组:常规护理 (gCONV) 和使用InsulinAPP (gAPP) 的eGMS协议.
主要结局是医院获得的感染,功能恶化和症状性心房律乱的组合;次要结局包括GC,低血糖,停留时间和费用.

主要成果:

gAPP组的平均葡萄糖水平较低 (167.2比188.7毫克/分升,P=.040) 和葡萄糖>180毫克/分升的日数较少 (51.3%比74.8%,P=.011).
主要综合结局发生在16%的gAPP患者中,而CgONV中为58% (P<.010).
在gAPP中,低血糖的发病率较低 (4%对16%,P=.046),住院时间较短,成本较低.

结论:

在CABG手术后,InsulinAPP协议有效地优化了T2DM患者的血糖控制.
这种eGMS可以减少不良结果,包括感染,脏恶化和心律失常.
在这种患者群体中,InsulinAPP为住院糖尿病患者的治疗提供了一个具有成本效益的解决方案.

关键词:

数字健康协议数字健康协议在医院治疗的高血糖症.胰岛素治疗中的胰岛素治疗.医疗信息学应用程序非危急病的住院患者.2型糖尿病是什么?

更多相关视频

Sleeve Gastrectomy in Mice using Surgical Clips

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique

Published on: January 26, 2024

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...